Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00972413 · ClinicalTrials.gov registry record · Phase 1

Cone Beam Computed Tomography for Breast Imaging

A Phase 1 study of Breast Cancer, sponsored by Koning Corporation.

Completed
Registry status
Phase 1
Development phase
104
Enrollment target
1
Study location

NCT00972413: Completed Phase 1 study of Breast Cancer, sponsored by Koning Corporation.

NCT00972413 is a Phase 1 study of Breast Cancer that has completed, run by Koning Corporation. The registered enrollment target is 104 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00972413, a Phase 1 study of Breast Cancer, has completed, sponsored by Koning Corporation.

COMPLETED
Registry status
Phase 1
Development phase
104 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this study is to investigate the use of cone beam computed tomography (CBCT) for breast imaging in the diagnostic setting by providing a compelling body of evidence incorporating both non-contrast and contrast enhanced CBCT in the study protocol. The goal is to accumulate a body of evidence to provide data to incorporate CBCT into the diagnostic work-up of breast lesions.

Conditions Studied

Interventions

  • RADIATION Computed Tomography

Study Locations (1)

New York

  • Elizabeth Wende Breast Care - Rochester

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2008-06
Est. Completion 2012-05
Phase Phase 1

Sponsor

Koning Corporation

7 total trials

What the Registry Record Tells You About NCT00972413

The ClinicalTrials.gov registry entry for NCT00972413 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The listed sponsor is Koning Corporation, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Computed Tomography is the first listed.

NCT00972413 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00972413 about?

NCT00972413 is a clinical study titled "Cone Beam Computed Tomography for Breast Imaging". The primary aim of this study is to investigate the use of cone beam computed tomography (CBCT) for breast imaging in the diagnostic setting by providing a compelling body of evidence incorporating both non-contrast and contrast enhanced CBCT in the study protocol. The goal is to accumulate a body o...

What is the current status of trial NCT00972413?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 104 participants. The study started on 2008-06. Estimated completion is 2012-05.

What conditions does trial NCT00972413 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00972413?

The interventions under investigation include: Computed Tomography (RADIATION).

Who is sponsoring clinical trial NCT00972413?

This trial is sponsored by Koning Corporation, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00972413 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.